It has been shown to improve diabetes and promote cardioprotection
This article explains the gastrointestinal effects of GLP-1 therapy and provides practical guidance for managing bowel changes during treatment
This analysis also indicated that sitagliptin was the only DPP-4 inhibitor that improved insulin resistance when used as monotherapy
Research has documented MT-1s anti-inflammatory effects across skin cell models and systemic inflammatory models , characterising NF-B suppression, reduced TNF-alpha and IL-6 production, neutrophil activation inhibition, and anti-inflammatory effects in ischaemia-reperfusion and colitis models through MC1R-cAMP-mediated mechanisms
However, chronic peripheral stimuli, such as microbial metabolites, endotoxins, and systemic cytokines, gradually convert immune cells into primed, hyper-responsive states that do not resolve [134]